Showing results (41-50 of 65) with videos related to
Sort By:
Pageof 7
Endocrine|July 14, 2017
Cushing's syndrome: a model for sarcopenic obesityMichael Drey, Christina M Berr, Martin Reincke, et al.Pituitary|December 25, 2014
Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trialJochen Schopohl, Feng Gu, Robert Rubens, et al.European Journal of Endocrinology|May 17, 2019
Determinants of the growth hormone nadir during oral glucose tolerance test in adultsKatharina Schilbach, Christina Gar, Andreas Lechner, et al.Reproductive Biology and Endocrinology : RB&E|April 22, 2024
Pregnancy and acromegaly: clinical outcomes of retrospectively analysed data from the German acromegaly registryAnke Tönjes, Marleen Würfel, Marcus Quinkler, et al.European Journal of Endocrinology|May 8, 2025
Soluble alpha klotho-impact of biological variables and reference intervals for adultsJúnia Ribeiro de Oliveira Longo Schweizer, Katharina Schilbach, Michael Haenelt, et al.European Journal of Endocrinology|March 21, 2015
Reduced sleep quality and depression associate with decreased quality of life in patients with pituitary adenomasSarah M Leistner, Jens Klotsche, Christina Dimopoulou, et al.Clinical Endocrinology|February 20, 2009
Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patientsCaroline Sievers, Christina Dimopoulou, Hildegard Pfister, et al.Clinical Endocrinology|February 19, 2014
Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III studyRosario Pivonello, Stephan Petersenn, John Newell-Price, et al.Journal of Clinical Pharmacology|May 8, 2014
Pharmacokinetics, pharmacodynamics, and safety of pasireotide LAR in patients with acromegaly: a randomized, multicenter, open-label, phase I studyStephan Petersenn, Jens Bollerslev, Ayman M Arafat, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 7, 2020
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Acromegaly in Routine Clinical Practice in Germany, Austria and SwitzerlandSylvère Störmann, Jochen Schopohl, Catharina Bullmann, et al.Pageof 7